1. Babazade R, Turan A. Pharmacokinetic and pharmacodynamic evaluation of sublingual sufentanil in the treatment of post-operative pain. Expert Opinion on Drug Metabolism & Toxicology. 2016;12(2):217-224.
2. Medscape. Sufenta (sufentanil) dosing, indications, interactions, adverse effects, and more [Internet]. Reference.medscape.com. Available from: https://reference.medscape.com/drug/sufenta-sufentanil-343325#0
3. National Center for Biotechnology Information. PubChem Database. Sufentanil, CID=41693, https://pubchem.ncbi.nlm.nih.gov/compound/Sufentanil
4. Van de Donk T, Ward S, Langford R, Dahan A. Pharmacokinetics and pharmacodynamics of sublingual sufentanil for postoperative pain management. Anaesthesia. 2017;73(2):231-237.
5. Food and Drugs Administration. Sufentanil Citrate Injection, USP CII [Internet]. Accessdata.fda.gov. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019050s032lbl.pdf
6. Therapeutic Goods Administration. Australian Public Assessment Report for Fentanyl citrate [Internet]. Tga.gov.au. 2015. Available from: https://www.tga.gov.au/sites/default/files/auspar-fentanyl-citrate-150422.pdf
7. Reece-Stremtan S, Campos M, Kokajko L, Brodribb W, Noble L, Brent N et al. ABM Clinical Protocol #15: Analgesia and Anesthesia for the Breastfeeding Mother, Revised 2017. Breastfeeding Medicine. 2017;12(9):500-506.
8. Food and Drug Administration. DSUVIA (sufentanil) sublingual tablet, 30 mcg [Internet]. Fda.gov. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209128s000lbl.pdf